Arun Alphonse Ignatius

Arun Alphonse Ignatius has extensive work experience in the biotechnology and pharmaceutical industry. Arun is currently the Director at MacroGenics, Inc., a position they have held since April 2021. Prior to that, they worked at Pfizer for nine years, where they held various roles including Senior Principal Scientist/Group Leader, Principal Scientist/Group Leader, and Principal Scientist.

Before joining Pfizer, Ignatius worked as a Senior Scientist at Cook Pharmica from 2009 to 2011. In this role, they led analytical and formulation projects for preclinical and clinical phase parenteral products, developed and qualified analytical methods, and authored technical reports for the successful technology transfer.

In addition to their industry experience, Ignatius also has academic experience. Arun served as an Adjunct Faculty in the Biotechnology Program at Ivy Tech Community College from 2010 to 2011. Arun also worked as a Research Scientist at Indiana University Bloomington from 2004 to 2009, where they contributed to the design and functioning of a biomolecular NMR facility and conducted research on allosteric switches in winged helix bacterial repressor proteins.

Ignatius began their career as a Postdoctoral Research Fellow at Vanderbilt University Medical Center from 2000 to 2004. Arun'sresearch focused on the molecular basis of Replication Protein A functions in the DNA replication pathway.

Overall, Ignatius has a strong background in research, development, and leadership roles in the biotechnology and pharmaceutical industry, as well as experience in academia.

Arun Alphonse Ignatius obtained a PhD in Biochemistry from the National Tsing Hua University. No specific timeframe was mentioned for this educational achievement.